EarningsQ2 2025 Earnings Report

Agios Pharma (8AP) Q2 2025 Earnings Report

1 Followers

CH:8AP Q2 2025 EPS Results

Actual EPS-CHF1.59

Consensus EPS-CHF1.49

Beat/MissMissed by -CHF0.10

One Year Ago EPS-CHF1.39

Actual RevenueCHF10.26M

Expected RevenueCHF7.84M

Beat/MissBeat by +CHF2.42M

YoY Revenue Growth+44.57%

QuarterQ2 2025

Date07/31/2025

TimeBefore Open

Conference CallThursday, July 31, 2025

CH:8AP Upcoming Earnings

Agios Pharma's next earnings date is estimated for November 5, 2026, based on past reporting schedules.

CH:8AP Q2 2025 Earnings Call

0:00 / 0:00

No earnings call summary is available for this earnings event.

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change
Nov 05, 2026	2026 (Q3)	-1.02 / -	-1.466	―
Jul 30, 2026	2026 (Q2)	-1.36 / -1.39	-1.59	12.44% (+0.20)
Apr 29, 2026	2026 (Q1)	-1.49 / -1.39	-1.277	-9.03% (-0.12)
Feb 12, 2026	2025 (Q4)	-1.61 / -1.53	-1.186	-29.17% (-0.35)
Oct 30, 2025	2025 (Q3)	-1.56 / -1.47	13.363	-110.97% (-14.83)
Jul 31, 2025	2025 (Q2)	-1.49 / -1.59	-1.392	-14.20% (-0.20)
May 01, 2025	2025 (Q1)	-1.46 / -1.28	-1.195	-6.90% (-0.08)
Feb 13, 2025	2024 (Q4)	-1.39 / -1.19	-1.409	15.79% (+0.22)
Oct 31, 2024	2024 (Q3)	12.54 / 13.36	-1.351	1089.02% (+14.71)
Aug 01, 2024	2024 (Q2)	-1.32 / -1.39	-1.244	-11.92% (-0.15)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed